Biotech Acquisition Company Unit
BIOTU
BIOTU was delisted on the 2nd of February, 2023.
34 hedge funds and large institutions have $45.2M invested in Biotech Acquisition Company Unit in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 8 closing their positions.
17% less funds holding
Funds holding: 41 → 34 (-7)
25% less capital invested
Capital invested by funds: $60.1M → $45.2M (-$14.9M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$213K |
| 2 |
VF
Virtu Financial
New York
|
+$168K |
| 3 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$100K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$25K |
| 5 |
Walleye Capital
New York
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRCM
Sage Rock Capital Management
New York
|
-$5.78M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$4.01M |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$2.2M |
| 4 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$2.02M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.51M |
BIOTU Hedge Fund Activity: Q3 2021 in Review
34 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Unit (BIOTU) for Q3 2021, worth a combined $45.2M — down 25% from $60.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BIOTU and 1 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was State of Wisconsin Investment Board, adding an estimated $213K. The largest seller was Sage Rock Capital Management, exiting entirely with an estimated $5.78M sold.
- 34 institutional investors held Biotech Acquisition Company Unit (BIOTU) as of Q3 2021, down from 41 in Q2 2021.
- Funds reported $45.2M of Biotech Acquisition Company Unit stock for Q3 2021, down 25% quarter-over-quarter.
- 1 fund opened new Biotech Acquisition Company Unit positions in Q3 2021 and 8 closed out, a net change of -7 holders.
- The largest Biotech Acquisition Company Unit buyer in Q3 2021 was State of Wisconsin Investment Board, an estimated $213K added.
- The largest Biotech Acquisition Company Unit seller in Q3 2021 was Sage Rock Capital Management, an estimated $5.78M sold.
Based on aggregated 13F filings for Q3 2021.